## The evolving Landscape of Performance-Enhancing Drug Testing in Major League Baseball
Major League Baseball (MLB) continues to refine its approach to performance-enhancing drugs (PEDs), with the latest data revealing a notable decrease in Therapeutic Use Exemptions (tues) granted for attention Deficit Hyperactivity Disorder (ADHD). In 2025, a record low of 54 players received permission to use medications like Adderall, Ritalin, and Vyvanse, a notable drop from 61 in the previous year and a dramatic decline from the 119 approvals recorded in 2013. This shift, detailed in the annual report by MLB’s autonomous program administrator, Thomas M. Martin, signals a changing dynamic in how players manage health conditions and navigate the league’s stringent drug policies. But what does this decline *really* meen for the future of the game, and what other trends are emerging in MLB’s ongoing battle against doping?
### H2: Understanding the Decline in ADHD Medication Exemptions
The decrease in ADHD medication exemptions isn’t necessarily indicative of fewer players *having* ADHD. Several factors likely contribute to this trend. Increased awareness of the rules, stricter enforcement, and a potential shift towards alternative treatment methods could all play a role.Players may be more hesitant to apply for TUEs due to the scrutiny involved, or they might be exploring non-pharmacological approaches to manage their condition.
Did You Know? The most commonly prescribed medications for ADHD – Adderall, Ritalin, and Vyvanse – are stimulants. While legally prescribed for ADHD, they can also be misused to enhance athletic performance, leading to their inclusion on MLB’s banned substance list.
Moreover, MLB’s ongoing efforts to educate players about the prohibited substance list and the application process for TUEs are likely having an impact. The league has invested heavily in resources to ensure players understand the rules and the potential consequences of violations. Are we seeing a genuine decrease in need, or simply a change in reporting and management of ADHD within the league?
### H2: Extensive Drug testing Statistics & Recent Violations
Beyond ADHD, MLB’s drug testing program remains robust. A total of 11,700 drug tests were collected during the period ending with the 2025 World Series, slightly below the record of 11,783 from the previous year. This included 9,400 urine samples and 2,300 blood samples specifically targeting Human Growth Hormone (HGH). The focus on blood testing for HGH is especially significant, as it’s a tough substance to detect and has been a long-standing concern for MLB.
However, despite the extensive testing, violations still occur. In 2025, two players on 40-man rosters tested positive and faced discipline:
| Player | Team | Substance | Penalty |
|---|---|---|---|
| Jurickson Profar | Atlanta Braves | Chorionic Gonadotrophin | 80-game suspension |
| José Alvarado | Philadelphia Phillies | External Testosterone | 80-game suspension |
These cases highlight the ongoing challenge of preventing players from using banned substances, even unintentionally. Profar’s claim of unknowingly ingesting a banned substance and Alvarado’s description involving a weight loss drug underscore the complexities of maintaining a clean sport.
Pro Tip: Players should meticulously review *all* ingredients in any supplement or medication they take, even over-the-counter products, to ensure compliance with MLB’s banned substance list. Consulting with the MLB Players Association (MLBPA) is highly recommended.
### H2: The Future of PED Testing in Baseball: Emerging Trends & Technologies
MLB isn’t resting on its laurels.The league is continually exploring new technologies and strategies to enhance its drug testing program. Recent research from the National Institute on Drug
Related reading